DAIHAN Scientific Management
Management criteria checks 2/4
DAIHAN Scientific's CEO is Hyun Jeong Shu, appointed in Apr 2019, has a tenure of 6.5 years. directly owns 5.42% of the company’s shares, worth ₩1.89B. The average tenure of the management team and the board of directors is 3.7 years and 4.8 years respectively.
Key information
Hyun Jeong Shu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.5yrs |
| CEO ownership | 5.4% |
| Management average tenure | 3.7yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Shareholders Can Be Confident That DAIHAN Scientific's (KOSDAQ:131220) Earnings Are High Quality
Aug 27
Optimistic Investors Push DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares Up 29% But Growth Is Lacking
Apr 21Does DAIHAN Scientific (KOSDAQ:131220) Deserve A Spot On Your Watchlist?
Apr 12A Look At The Fair Value Of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)
Mar 29The DAIHAN Scientific (KOSDAQ:131220) Share Price Has Gained 173%, So Why Not Pay It Some Attention?
Mar 11Shareholders Are Loving DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) 0.4% Yield
Feb 18We Like These Underlying Trends At DAIHAN Scientific (KOSDAQ:131220)
Jan 24
What Type Of Shareholders Own The Most Number of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares?
Dec 27DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) Stock Is Going Strong: Is the Market Following Fundamentals?
Nov 30Is DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) A Good Fit For Your Dividend Portfolio?
Jul 14CEO
Hyun Jeong Shu
Ms. Hyun Jeong Shu has been Chief Executive Officer at DAIHAN Scientific Co., Ltd. since 2022 and serves as President since April 2019 and also serves as Director. Ms. Shu served as Chief Operating Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.5yrs | no data | 5.42% ₩ 1.9b | |
| CFO & Director | 3.7yrs | no data | no data | |
| CTO, CEO of Local Service of DAIHAN Labservice & Director | 1.8yrs | no data | no data | |
| Marketing Director & Director | 5.8yrs | no data | no data | |
| CGO, CEO of Openmarket ALLforLAB & Director | 3.8yrs | no data | 0.95% ₩ 331.6m | |
| Executive Director & CEO of Global Business - SciLab Korea Co. | 3.7yrs | no data | 0.34% ₩ 117.1m | |
| Chief Executive Officer of Laboratory Store ALL LAB | 2.6yrs | no data | 0.027% ₩ 9.3m | |
| CPO & Director | 3.7yrs | no data | no data | |
| Sales Director of National Market & Director | 3.8yrs | no data | no data | |
| Chief Executive Officer of Analysis Instruments Business-DAIHAN Analytics Co. | no data | no data | no data | |
| Co-President of Vietnam Market - DAIHAN Scientific Vietnam | no data | no data | no data | |
| Chief Executive Officer of Area Market - DAIHAN Scientific Daegu | no data | no data | no data |
Experienced Management: A131220's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | no data | no data | 5.42% ₩ 1.9b | |
| CFO & Director | 5.8yrs | no data | no data | |
| CTO, CEO of Local Service of DAIHAN Labservice & Director | 1.8yrs | no data | no data | |
| Marketing Director & Director | 5.8yrs | no data | no data | |
| CGO, CEO of Openmarket ALLforLAB & Director | no data | no data | 0.95% ₩ 331.6m | |
| Executive Director & CEO of Global Business - SciLab Korea Co. | no data | no data | 0.34% ₩ 117.1m | |
| CPO & Director | no data | no data | no data | |
| Sales Director of National Market & Director | 3.8yrs | no data | no data | |
| Chairman | 6.5yrs | no data | 16.93% ₩ 5.9b | |
| Director | no data | no data | no data | |
| Director | no data | no data | no data | |
| Chairman of Vietnam Market - SciLab-Vietnam | 3.7yrs | no data | no data |
Experienced Board: A131220's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/24 11:40 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DAIHAN Scientific Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.